(MENAFN- GlobeNewsWire - Nasdaq) The North America Beta Glucan Market, valued at USD 204.03 million in 2024, is poised to grow to USD 373.85 million by 2033, with a CAGR of 6.96% from 2025 to 2033. This growth is driven by rising consumer demand for immune-boosting and functional food ingredients and increased awareness of beta glucan's health benefits. Beta glucan-a soluble fiber found in grains, fungi, and yeast-offers cholesterol-reducing and immune-modulating properties, gaining traction in functional foods, nutraceuticals, and cosmetics. Challenges include high production costs and limited consumer awareness. Key markets include the U.S., Canada, and Mexico, with significant expansion in the health and wellness industries.Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "North America Beta-Glucan Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The North America Beta Glucan Market was valued at USD 204.03 million in 2024 and is expected to grow to USD 373.85 million by 2033, growing at a CAGR of 6.96% from 2025 to 2033. The growth is due to increasing consumer demand for immune-boosting ingredients, enhanced application in functional foods and dietary supplements, and rising awareness of the health benefits of beta glucan throughout the region.
With an increased emphasis on preventive health and clean-label ingredients, North American consumers are increasingly looking for products containing beta glucan. The ingredient's established health benefits combined with high demand for natural and plant-based additives continue to drive its traction across mainstream as well as niche health product categories.
Growth Driver in the North America Beta Glucan Market
Increased Demand for Functional Foods
The increased demand for functional foods by North American consumers is largely fueling the beta glucan market. As consumers take more interest in their health, they are increasingly looking for food products providing extra benefits other than plain nutrition. Beta glucan, with its properties of lowering cholesterol and improving immunity, is a perfect fit for this demand. Manufacturers are incorporating it into cereals, beverages, and snack bars, driving demand throughout the region.
Growing Nutraceuticals Industry
The fast growth of the nutraceuticals industry in North America is another key driver for beta glucan. As consumers opt for dietary supplements for immunity and heart health, beta glucan is being widely used for its proven bioactive properties. Incorporation in tablets, powders, and health drinks has opened up market opportunities, particularly as the aging population looks for preventative health products.
Feb 2025, Layn Natural Ingredients has opened a more extensive biotechnology plant to specialize in precision fermentation and enzyme-based technology. This plant will maximize large-scale production of eco-friendly bioactive ingredients, further increasing Layn's efficiency and sustainability in manufacturing pure ingredients.
More Research and Clinical Validation
Continuing clinical studies and increased scientific endorsement of the benefits of beta glucan are driving market expansion. Research affirming its effectiveness in reducing cholesterol, stimulating immune function, and regulating blood sugar is adding to its credibility and usage by health professionals and consumers alike. This expanding body of evidence has spawned regulatory endorsement and wider use in food and pharmaceutical applications. June 2024: Cargill's barley beta-glucan concentrate will gain new health claim approval from the U.S. Food and Drug Administration (FDA), associating the ingredient with a lower risk of heart disease.
Challenges in the North America Beta Glucan Market
High Production and Extraction Costs
One of the primary issues in the North America beta glucan market is the production and extraction cost. The extraction of beta glucan from oats, barley, or mushrooms is a capital-intensive process that demands advanced machinery and technology, thus elevating the overall production cost of the final product. This makes it difficult to use it in price-sensitive markets and confines small-scale companies from joining the industry.
Limited Consumer Awareness
Though it has advantages, beta glucan is still not well-known among mainstream consumers in North America. It is still not well understood by many regarding its sources and possible health impacts, which can limit demand. Without proper awareness campaigns and education programs, the market's growth potential is not being fully utilized, particularly among mainstream food consumers who are not knowledgeable about functional ingredients.
Key Players Analysis: Overviews, Key Persons, Recent Developments, Revenue
Koninklijke Philips N.V. EDAP TMS S.A Johnson & Johnson Medtronic Plc. Hitachi Ltd. Theraclion Stryker General Electrics
Key Attributes:
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment